Lam W - Search Results

1

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.

Wang E, Bussom S, Chen J, Quinn C, Bedognetti D, Lam W, Guan F, Jiang Z, Mark Y, Zhao Y, Stroncek DF, White J, Marincola FM, Cheng YC. Wang E, et al. Among authors: lam w. BMC Med Genomics. 2011 May 11;4:38. doi: 10.1186/1755-8794-4-38. BMC Med Genomics. 2011. PMID: 21569348 Free PMC article.

2

X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.

Park SY, Lam W, Cheng YC. Park SY, et al. Among authors: lam w. Cancer Res. 2002 Jan 15;62(2):459-65. Cancer Res. 2002. PMID: 11809696

3

Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates.

Liou JY, Dutschman GE, Lam W, Jiang Z, Cheng YC. Liou JY, et al. Among authors: lam w. Cancer Res. 2002 Mar 15;62(6):1624-31. Cancer Res. 2002. PMID: 11912132

4

Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates.

Lam W, Li Y, Liou JY, Dutschman GE, Cheng YC. Lam W, et al. Mol Pharmacol. 2004 Feb;65(2):400-6. doi: 10.1124/mol.65.2.400. Mol Pharmacol. 2004. PMID: 14742682

5

Novel mode of action of tylophorine analogs as antitumor compounds.

Gao W, Lam W, Zhong S, Kaczmarek C, Baker DC, Cheng YC. Gao W, et al. Among authors: lam w. Cancer Res. 2004 Jan 15;64(2):678-88. doi: 10.1158/0008-5472.can-03-1904. Cancer Res. 2004. PMID: 14744785

6

Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.

Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Leung CH, et al. Among authors: lam w. Mol Pharmacol. 2005 Aug;68(2):286-97. doi: 10.1124/mol.105.012765. Epub 2005 May 4. Mol Pharmacol. 2005. PMID: 15872117

7

Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).

Lam W, Park SY, Leung CH, Cheng YC. Lam W, et al. Mol Pharmacol. 2006 May;69(5):1607-14. doi: 10.1124/mol.105.021527. Epub 2006 Feb 15. Mol Pharmacol. 2006. PMID: 16481390

8

The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.

Lam W, Leung CH, Bussom S, Cheng YC. Lam W, et al. Mol Pharmacol. 2007 Sep;72(3):536-44. doi: 10.1124/mol.106.033472. Epub 2007 Jun 12. Mol Pharmacol. 2007. PMID: 17565005

9

Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.

Lam W, Bussom S, Cheng YC. Lam W, et al. Mol Cancer Ther. 2009 Feb;8(2):415-23. doi: 10.1158/1535-7163.MCT-08-0692. Epub 2009 Feb 10. Mol Cancer Ther. 2009. PMID: 19208827

10

Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.

McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson DM 3rd. McNeill DR, et al. Among authors: lam w. Mol Cancer Res. 2009 Jun;7(6):897-906. doi: 10.1158/1541-7786.MCR-08-0519. Epub 2009 May 26. Mol Cancer Res. 2009. PMID: 19470598 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,003 results

Search Page

Filters